Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Novanta | NOVT | Nov 26, 2024 | 166.62 | -3.93 |
Novartis ADR | NVS | Nov 26, 2024 | 103.81 | +0.26 |
Novavax | NVAX | Nov 26, 2024 | 8.75 | -6.12 |
Novo Integrated Sciences | NVOS | Nov 26, 2024 | 0.17 | 0.00 |
Novo Nordisk ADR | NVO | Nov 26, 2024 | 106.13 | +1.50 |
NovoCure | NVCR | Nov 26, 2024 | 17.88 | -4.79 |
Novonix ADR | NVX | Nov 26, 2024 | 2.69 | 0.00 |
NRG Energy | NRG | Nov 26, 2024 | 101.16 | +10.11 |
NRx Pharmaceuticals | NRXP | Nov 26, 2024 | 1.27 | -3.05 |
NSTS Bancorp | NSTS | Nov 26, 2024 | 11.28 | +1.53 |
Nu Holdings | NU | Nov 26, 2024 | 13.94 | -2.04 |
Nu Skin Enterprises | NUS | Nov 26, 2024 | 7.44 | -1.46 |
Nuburu | BURU | Nov 26, 2024 | 0.45 | +0.45 |
NuCana ADR | NCNA | Nov 26, 2024 | 1.33 | +5.56 |
Nucor | NUE | Nov 26, 2024 | 154.00 | +0.37 |
Nukkleus | NUKK | Nov 26, 2024 | 1.60 | -4.19 |
Nurix Therapeutics | NRIX | Nov 26, 2024 | 21.79 | -0.14 |
NuScale Power | SMR | Nov 26, 2024 | 26.34 | -6.13 |
Nustar Energy C Pref | NS-C | Nov 26, 2024 | 24.99 | 0.00 |
Nutanix A | NTNX | Nov 26, 2024 | 72.35 | -0.62 |
Nutex Health | NUTX | Nov 26, 2024 | 35.00 | +2.28 |
Nutriband | NTRB | Nov 26, 2024 | 4.77 | +0.42 |
Nutrien | NTR | Nov 26, 2024 | 45.90 | -1.92 |
Nuvalent A | NUVL | Nov 26, 2024 | 96.30 | +0.71 |
Nuvation Bio A | NUVB | Nov 26, 2024 | 2.89 | 0.00 |
Nuvectis Pharma | NVCT | Nov 26, 2024 | 5.15 | +4.04 |
Nuveen Amtfree Municipal Credit Income Fund | NVG | Nov 26, 2024 | 13.00 | +0.78 |
Nuveen Amtfree Municipal Value Fund | NUW | Nov 26, 2024 | 13.89 | -0.29 |
Nuveen Amtfree Quality Municipal Income Fund | NEA | Nov 26, 2024 | 11.72 | +0.43 |
Nuveen Arizona Quality Municipal Fund | NAZ | Nov 26, 2024 | 12.19 | -0.82 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.